Clinical Trial Update: Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effects of systemic nitric oxide inhibition on renal hemodynamics in people with autosomal dominant polycystic kidney disease and gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Glomerulonephritis

Snippet

Sponsor: Regional Hospital Holstebro | Conditions: ADPKD, Glomerulonephritis | Phase 1 | Status: COMPLETED